TORNTPHARM Intraday Analysis...

TORNTPHARM Share Price

Open 1176.35 Change Price %
High 1190.00 1 Day 2.45 0.21
Low 1168.70 1 Week -33.85 -2.79
Close 1178.00 1 Month -85.60 -6.77
Volume 113479 1 Year -166.60 -12.39
52 Week High 1769.50
52 Week Low 1141.95
TORNTPHARM Important Levels
Resistance 2 1197.75
Resistance 1 1189.61
Pivot 1178.90
Support 1 1166.39
Support 2 1158.25
NSE INDIA Most Active Stocks
JPASSOCIAT 18.75 14.33%
GMRINFRA 21.35 2.64%
RCOM 21.20 5.47%
IBREALEST 204.45 6.48%
FORTIS 172.50 -12.83%
SBIN 288.95 -1.88%
SUZLON 18.40 -1.60%
HDIL 85.85 -1.27%
DLF 192.05 -1.92%
ICICIBANK 291.85 0.78%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
SPYL 0.30 20.00%
KARMAENG 46.95 19.92%
ARCOTECH 96.65 19.32%
CIGNITITEC 303.35 14.75%
JPASSOCIAT 18.75 14.33%
SHRIRAMEPC 26.65 11.51%
TI 12.15 9.95%
TI 12.15 9.95%
SAMTEL 0.60 9.09%
More..
NSE INDIA Top Losers Stocks
RASOYPR 0.10 -33.33%
REIAGROLTD 0.30 -14.29%
FORTIS 172.50 -12.83%
SPCENET 0.40 -11.11%
NICCO 0.40 -11.11%
IFBAGRO 431.85 -8.20%
CASTEXTECH 7.90 -7.60%
NEXTMEDIA 20.15 -6.93%
ANKITMETAL 1.35 -6.90%
ESL 4.15 -6.74%
More..

Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)

TORNTPHARM Technical Analysis 5
As on 23rd Jun 2017 TORNTPHARM Share Price closed @ 1178.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1400.35 & Strong Sell for SHORT-TERM with Stoploss of 1312.41 we also expect STOCK to react on Following IMPORTANT LEVELS.
TORNTPHARM Target for June
1st Target up-side 1394.6
2nd Target up-side 1507.73
3rd Target up-side 1620.86
1st Target down-side 1071.8
2nd Target down-side 958.67
3rd Target down-side 845.54
TORNTPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 33.16 Sideways
MFI (14) MFI is 54.71 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 1248.90
10 Day Avg Volume Traded -22.34 % Less then 10 Day Average Volume
TORNTPHARM Other Details
Segment EQ
Market Capital 16629527552.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.torrentpharma.com
TORNTPHARM Address
TORNTPHARM
Off. Ashram Road
Ahmedabad, 380009
India
Phone: 91 79 2658 5090
Fax: 91 79 2658 2100
Interactive Technical Analysis Chart Torrent Pharmaceuticals Limited ( TORNTPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Torrent Pharmaceuticals Limited
TORNTPHARM Business Profile
Torrent Pharmaceuticals Limited, a pharmaceutical company, engages in the manufacture and sale of branded and unbranded generic pharmaceutical products. The company offers its products primarily in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective, and pain management therapeutic areas. It offers products in the form of tablets, capsules, and parenterals. The company’s active pharmaceutical ingredients comprise nicorandil, risperidone, venlafaxine hydrochloride, ropinarole hydrochloride, duloxetine hydrochloride, ormeloxifen hydrochloride, nebivolol hydrochloride, lamotrigine, sertraline hydrochloride, and clopidogrel bisulphate; and level 1 area products include atomoxatine hydrochloride, rivastigmine hydrogen tartrate, and esomeprazole sodium. It is also involved in the provision of contract manufacturing services primarily for human insulin. Torrent Pharmaceuticals Limited primarily sells its products in India, the United States, Brazil, Europe, Russia, the Asia Pacific, Africa, and CIS countries. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. Torrent Pharmaceuticals Limited was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Ltd operates as a subsidiary of Torrent Private Limited.